The "Intensive Review of Nephrology" course is designed to enhance renal medicine knowledge by offering a comprehensive update; a case-based review of challenging clinical problems; and a review of literature to guide evidence-based practice. This course can also serve to prepare attendees for the ABIM Board Examinations (Certification/Recertification) and offers daily board review question and answer practice sessions in each specialty area of nephrology. This program also consists of daily case-based lectures and case-based luncheons covering the most important topics in renal medicine. Throughout the course, emphasis is placed on the practical application of physiological principles to the understanding and management of clinical problems, particularly for board exam preparation.
HDCN is pleased to present a selection of a number of presentations from this annual course. For more information on future courses, which take place every summer in Boston, usually in August, please Click Here
|See Individual Lecture Pages|
This educational activity is an audio recording with accompanying slides of a live presentation held
in August, 2018 in Boston, MA. The presentation was prepared under CME guidelines but no CME credit is available for this particular Web archive.
Release Date: January 01, 2019
To participate in this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (downloadable from www.microsoft.com) the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from www.adobe.com) is required to see the full-screen slide/audio presentations and the video presentations.
This presentation is among a number of presentations available in archived form from the Harvard Medical School Department of Continuing Education. For more information about the Harvard Intensive Review of Nephrology, please Click this link
| SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE: |
Harvard Medical School has long held the standard that its continuing medical education courses are free of commercial bias.
In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers, course planners, and content reviewers have been asked to disclose any relationship they, or their spouse or partner, have to companies producing pharmaceuticals, medical equipment or devices. In addition, faculty have been asked to list any off label uses they will discuss of pharmaceuticals and devices for investigatioal and non-FDA approved purposes.
Such dislcose is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk.
Because this course is meant to educate physicians with what is currently in use and what may be
available in the future, there may be "off-label" use discussed in the presentations. Speakers have
been requested to inform the audience when off-label use is being discussed. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Harvard Medical School or the Brigham Hospital. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. Before prescribing any medicine, primary references and full prescribing information should be consulted.
The policy statements of HDCN related to posting of educational content are listed on this page.
For more information about the Harvard Renal Review Course, please see this link.